Jacob Hecksher-Sørensen Selected Research

Jacob Hecksher-Sørensen Research Topics

3	Body Weight (Weight, Body) 01/2022 - 10/2014
2	Weight Loss (Weight Reduction) 01/2022 - 10/2014
2	Obesity 01/2021 - 04/2016
2	Type 2 Diabetes Mellitus (MODY) 12/2018 - 10/2014
1	Insulin Resistance 01/2022
1	Metabolic Diseases (Metabolic Disease) 04/2021
1	Infarction (Infarctions) 01/2021
1	Myocardial Infarction 01/2021
1	Hypertrophy 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2020
1	Kidney Diseases (Kidney Disease) 06/2020
1	Parkinson Disease (Parkinson's Disease) 11/2019
1	Hemorrhage 12/2018
1	Atherosclerosis 12/2018
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2017
1	AIDS-Related Complex (ARC) 10/2014
1	Glucose Intolerance 01/2012

3	Liraglutide FDA Link 12/2018 - 10/2014
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 10/2014
2	LectinsIBA 01/2021 - 06/2020
2	Pharmaceutical PreparationsIBA 01/2021 - 12/2020
2	Insulin (Novolin)FDA Link 01/2017 - 01/2012
2	Blood Glucose (Blood Sugar)IBA 04/2016 - 10/2014
1	Peptides (Polypeptides)IBA 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 01/2022
1	Immunoglobulin G (IgG)IBA 01/2022
1	Islet Amyloid PolypeptideIBA 04/2021
1	Hormones (Hormone)IBA 04/2021
1	Amylin Receptor AgonistsIBA 04/2021
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2021
1	Captopril (Capoten)FDA LinkGeneric 01/2021
1	AlbuminsIBA 06/2020
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 11/2019
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 11/2019
1	CholesterolIBA 12/2018
1	semaglutideIBA 12/2018
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 12/2018
1	Extracellular Matrix ProteinsIBA 12/2018
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 10/2014
1	Glucagon-Like Peptide-1 ReceptorIBA 10/2014
1	Amphetamine (Amfetamine)FDA LinkGeneric 10/2014
1	Cocaine (Cocaine HCl)IBA 10/2014

1	Therapeutics 01/2021